ClassID:

20247

A61K31/202 - page 10 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Recent Application in this class:
#2701
20060147566
2006-07-06

Use of physiologically active fatty acids

#2702
20060147523
2006-07-06

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

#2703
20060142391
2006-06-29

PPARGAMMA-ACTIVATING PHARMACEUTICAL COMPOSITION

#2704
20060141022
2006-06-29

Soft capsule preparation

#2705
20060135610
2006-06-22

Cardiovascular compositions

#2706
20060135608
2006-06-22

Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia

#2707
20060135607
2006-06-22

Drug for improving prognosis for subarachnoid hemorrhage

#2708
20060134178
2006-06-22

Composition containing organic substance having double bond with improved oxidative stability

#2709
20060128804
2006-06-15

Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs

#2710
20060128803
2006-06-15

Method of treating dry eye disorders using 13(S)-HODE and its analogs

#2711
20060128714
2006-06-15

Maternal multi-nutrient against diabetes-related birth defects

#2712
20060127505
2006-06-15

Anti-inflammatory formulations

#2713
20060127491
2006-06-15

Treatment and prevention of liver disease associated with parenteral nutrition (PN)

#2714
20060122160
2006-06-08

Co-administration of dehydroepiandrosterone (DHEA) congener with parthenolide for treating inflammation

#2715
20060117414
2006-06-01

Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof

#2716
20060111437
2006-05-25

Hyperlipemia therapeutic agent

#2717
20060110476
2006-05-25

Dietary foodstuff for positively influencing cardiovascular health

#2718
20060105033
2006-05-18

Dietary composition containing conjugated linoleic acid and calcium for improved health

#2719
20060099693
2006-05-11

High-quality lipids produced by enzymatic liberation from biomass

#2720
20060099208
2006-05-11

Method of potentiating the therapeutic action of monoclonal and polyclonal antibodies

#2721
20060094784
2006-05-04

Tgf-alpha expression inhibitors

#2722
20060094654
2006-05-04

Neuroprotective complex for treatment of cerebral ischemia and injury

#2723
20060088573
2006-04-27

Composition having action preventing or alleviating symtoms or diseases due to aging of blood vessels

#2724
20060088502
2006-04-27

Drug for reducing side effects in ribavirin interferon combination therapy

#2725
20060084637
2006-04-20

Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same

#2726
20060079577
2006-04-13

Method for treating airway hyper-responsiveness with lipoxin analogs

#2727
20060078625
2006-04-13

Compositions including Krill extracts and conjugated linoleic acid and methods of using same

#2728
20060078597
2006-04-13

Ascorbic acid salt suspensions and use thereof as antioxidants

#2729
20060074051
2006-04-06

Therapeutic stem cell growth factor composition, anti-inflammatory composition, and uses thereof

#2730
20060073192
2006-04-06

Composition and method for use in cartilage affecting conditions

#2731
20060073187
2006-04-06

Composition for normalization of infradian rhythm

#2732
20060069163
2006-03-30

Method for treating Alzheimer's disease

#2733
20060069159
2006-03-30

Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation

#2734
20060069158
2006-03-30

Lipoxin compounds and their use in treating cell proliferative disorders

#2735
20060069075
2006-03-30

Methods for treating dry eye

#2736
20060063838
2006-03-23

Activators of peroxisome proliferator-activated receptors

#2737
20060063837
2006-03-23

Stabilized leukotriene B(LTB) agent pharmaceutical formulation

#2738
20060063836
2006-03-23

Method for treating renal disease

#2739
20060058384
2006-03-16

Treatment of IGA nephropathy with omega-3 fatty acids

#2740
20060057185
2006-03-16

Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person

#2741
20060052446
2006-03-09

Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders

#2742
20060041017
2006-02-23

Synergistic conjugated linoleic acid (CLA) and carnitine combination

#2743
20060039992
2006-02-23

Novel compositions and methods utilizing green-lipped mussel and fatty acids

#2744
20060035974
2006-02-16

Linoleic acid active agents for enhancing probability of becoming pregnant

#2745
20060035846
2006-02-16

Preventing/correcting functional disorders of the pilosebaceous unit of mammals

#2746
20060034944
2006-02-16

Compositions for improving breast health in women

#2747
20060034872
2006-02-16

Compositions and methods for preventing abuse of orally administered medications

#2748
20060034815
2006-02-16

Statin pharmaceutical compositions and related methods of treatment

#2749
20060029587
2006-02-09

Peri-operative and peri-procedure nutritional supplementation

#2750
20060025479
2006-02-02

Agents with leukotriene B-like antiviral (enveloped RNA) activities

#2751
20060024356
2006-02-02

Osteoarthritis diet formulations

#2752
20060020031
2006-01-26

Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses

#2753
20060014820
2006-01-19

Lipid-amino acid conjugates and methods of use

#2754
20060013870
2006-01-19

Pharmaceutical compositions of hops resins

#2755
20060009522
2006-01-12

Compositions and methods for treating eye disorders and conditions

#2756
20060009521
2006-01-12

Lipoxin analogs as novel inhibitors of angiogenesis

#2757
20060004100
2006-01-05

Method of improving animal tissue quality by supplementing the animal diet with oleic acid and selected tocols

#2758
20060004099
2006-01-05

Glycogen or polysaccharide storage disease treatment method

#2759
20060004076
2006-01-05

Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation

#2760
20050271596
2005-12-08

Vasoactive kit and composition and uses thereof

#2761
20050267212
2005-12-01

Omega-3 fatty acids in the treatment of depression

#2762
20050266051
2005-12-01

Pet food compositions and methods

#2763
20050261255
2005-11-24

Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma

#2764
20050250671
2005-11-10

Activators of peroxisome proliferator-activated receptor

#2765
20050249821
2005-11-10

Nutritional supplement for treatment of ocular diseases

#2766
20050244510
2005-11-03

Compositions for improving mental performance

#2767
20050239889
2005-10-27

In vivo release of endogenous anti-microbial mediators by leukotriene B4 (LTB4) administration

#2768
20050239876
2005-10-27

Tocopherol and tocotrienol aerosols

#2769
20050238589
2005-10-27

Methods and compositions for preventing or treating periodontal diseases

#2770
20050234127
2005-10-20

Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field

#2771
20050234075
2005-10-20

Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies

#2772
20050233013
2005-10-20

Methods for enhancing the transport of glucose for balancing blood sugar levels

#2773
20050232911
2005-10-20

Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid

#2774
20050222253
2005-10-06

Anti-cancer nitro- and thia-fatty acids

#2775
20050222050
2005-10-06

Compositions and methods for reducing or preventing obesity

#2776
20050215641
2005-09-29

Compositions comprising reverse isomers of conjugated linoleic acid

#2777
20050208162
2005-09-22

Esterified fatty acid composition

#2778
20050197395
2005-09-08

Compositions and methods for body weight management

#2779
20050192352
2005-09-01

Method for decreasing cartilage damage in dogs

#2780
20050187292
2005-08-25

Hyperlipemia therapeutic agent

#2781
20050182037
2005-08-18

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

#2782
20050182020
2005-08-18

Ceramide de novo synthesis-based therapeutic and prophylactic methods, and related articles of manufacture

#2783
20050176817
2005-08-11

Anti-inflammatory nitro- and thia- fatty acids

#2784
20050176816
2005-08-11

Anti-inflammatory nitro- and thia-fatty acids

#2785
20050176815
2005-08-11

Anti-inflammatory nitro-and thia-fatty acids

#2786
20050171200
2005-08-04

Use of EPA and DHA in secondary prevention

#2787
20050171151
2005-08-04

Methods of treating hyperlipidemia

#2788
20050170479
2005-08-04

Method for producing lipids by liberation from biomass

#2789
20050165105
2005-07-28

Method of using punicic acid to enhance immune response and prevent metabolic disorders

#2790
20050165100
2005-07-28

Conjugated fatty acid esters

#2791
20050164908
2005-07-28

Neuroprotective complex for treatment of cerebral ischemia and injury

#2792
20050159483
2005-07-21

Method of using punicic acid to enhance immune response and prevent metabolic disorders

#2793
20050148668
2005-07-07

Lipoxin compounds and their use in treating cell proliferative disorders

#2794
20050142209
2005-06-30

Aqueous alkaline solution for mineral supplementation, preparing method thereof and composition for prevention and improvement of osteoporosis containing the same

#2795
20050137256
2005-06-23

Use of arachidonic acid as a method of increasing skeletal muscle mass

#2796
20050137253
2005-06-23

Formulations and methods for treatment or amelioration of inflammatory conditions

#2797
20050130925
2005-06-16

Method and composition for enhancing PGE1 production in vascular endothelial and smooth muscle cells

#2798
20050129710
2005-06-16

Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids

#2799
20050113443
2005-05-26

Modulation of airway inflammation in patients with cystic fibrosis and related diseases

#2800
20050112668
2005-05-26

Methods of treating fat metabolism disorders

#2801
20050112210
2005-05-26

Eye nutritional supplement

#2802
20050112123
2005-05-26

Methods of treating proteinuria

#2803
20050106272
2005-05-19

Co-beadlet of dha and rosemary and methods of use

#2804
20050101563
2005-05-12

Method and compositions for the treatment and prevention of pain and inflammation

#2805
20050090556
2005-04-28

Compound for treatment of external secretion disorders

#2806
20050075399
2005-04-07

Methods and kits for enhancing ability to learn in a puppy or kitten

#2807
20050075398
2005-04-07

Neuroprotectin D1 protects against cellular apoptosis, stroke damage, alzheimer's disease and retinal diseases

#2808
20050074443
2005-04-07

Methods of attenuating autoimmune disease and compositions useful therefor

#2809
20050070498
2005-03-31

Enteral formulation

#2810
20050069593
2005-03-31

Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid

#2811
20050049308
2005-03-03

Apolipoprotein D degradation inhibitor

#2812
20050043405
2005-02-24

Omega-3 fatty acids for osteoarthritis

#2813
20050042312
2005-02-24

Solubility and Absorption Promoter

#2814
20050042256
2005-02-24

Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lipid level

#2815
20050037065
2005-02-17

NUTRITIONAL FORMULATIONS

#2816
20050032757
2005-02-10

Nutritional supplements

#2817
20050027004
2005-02-03

Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions

#2818
20050014826
2005-01-20

Synthesis of polyconjugated fatty acids

#2819
20050009779
2005-01-13

Preparation for improving the action of receptors

#2820
20050009140
2005-01-13

Elongase genes and uses thereof

#2821
20050004218
2005-01-06

Vaccenic acid

#2822
20050004165
2005-01-06

Composition and method for modulating BAR/FXR receptor activity

#2823
18980129
2025-05-06

Compositions and methods for treating endocrine diseases and disorders

#2824
18932631
2025-02-25

Composition for improving respiratory health of companion animals

#2825
18410512
2025-09-02

Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

#2826
18094541
2024-02-13

Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

#2827
17994014
2024-01-30

Algal botanical extracts rich in eicosapentaenoic acid as tri/di-glyceride conjugate

#2828
17682300
2025-01-07

Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

#2829
17169271
2022-06-07

Methods of treating amyotrophic lateral sclerosis

#2830
16953978
2022-04-12

Omega-3 containing compositions

#2831
16910849
2024-06-11

Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof

#2832
16658099
2022-03-08

Omega-3 fatty acid nutriceutical compositions and methods

#2833
16282025
2021-10-12

Eye health supplement with curcumin

#2834
15793978
2018-10-23

Methods and composition for suppression of deep seated fungal growth on skin

#2835
15788798
2018-08-21

Methods and composition for suppression of deep seated fungal growth on skin

#2836
15767010
2021-11-02

Capsule with internal diaphragm for improved bioavailability

#2837
15477433
2019-10-22

Omega-3 fatty acid nutriceutical composition and optimization method

#2838
15378081
2017-10-24

Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation

#2839
15054833
2018-08-07

Infant formulas having vitamin complexes with enhanced bioavailability

#2840
14999041
2017-04-25

Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women

#2841
14950030
2017-01-17

Method and compositions for treating chronic inflammatory disorders

#2842
14507125
2017-06-20

Anti-aging nutritional supplement compositions for animals

#2843
14251632
2017-04-04

Omega-3 fatty acid nutriceutical composition and optimization method

#2844
13912844
2017-06-20

Multi-component formulations for the treatment of cognitive decline including Alzheimer's disease

#2845
13910499
2016-02-23

Milkweed seed oil administered to animals

#2846
10485456
2020-08-18

Composition having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction

#2847
10065326
2014-09-23

Method of using omega-3 fatty acids